Phusis Therapeutics, Inc.

San Diego, CA

UEI
JGZFBDAL61C4
CAGE
5KGW3
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • Self Certified Small Disadvantaged Business
  • For Profit Organization
  • Woman Owned Small Business
  • Woman Owned Business
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
6019 Folsom Dr, La Jolla, CA 92037, USA

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Award Agency Obligated Awarded
Clinical evaluation of a novel AKT/PDK1 inhibitor, PHT-427, for the treatment of multi-field actinitc keratoses R44CA306740 National Cancer Institute (NIH) $2,085,765
Targeting ERK5 for colorectal cancer therapy R21CA244691 National Cancer Institute (NIH) $752,435
Inhibiting multi-functional aldoa for cancer therapy R01CA216424 National Cancer Institute (NIH) $4,192,845
Inhibiting PLEKHA7 for mutant kras therapy R43CA186292 National Institutes of Health $225,000
Targeting mutant kras for cancer therapy R43CA171345 National Institutes of Health $287,434

Similar vendors

Vendor Location Primary NAICS
Primetime Life Sciences, LLC UEI UK3VUKCQM7N4 Germantown, MD 541714 Research and Development in Biotechnology (except Nanobiotechnology)
Phoenicia Biosciences, Inc. UEI NPAHDFK9M323 Weston, MA 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Vireo Systems Inc. UEI Z6AJPJ82PFK3 Nashville, TN 325411 Medicinal and Botanical Manufacturing
Epigenetix, Inc. UEI KVPSHD32BK67 Delray Beach, FL 541714 Research and Development in Biotechnology (except Nanobiotechnology)
Candel Therapeutics, Inc. UEI MPKRJM6FJFL8 Needham, MA 541714 Research and Development in Biotechnology (except Nanobiotechnology)

See more similar vendors on GovTribe

SBA capabilities narrative

From the vendor's SBA profile

research, drug discovery and development

Quick answers

Is Phusis Therapeutics, Inc. registered in SAM.gov?

Yes. Phusis Therapeutics, Inc.'s SAM.gov registration is active through April 10, 2027.

What is Phusis Therapeutics, Inc.'s CAGE code?

Phusis Therapeutics, Inc.'s CAGE code is 5KGW3, and its Unique Entity ID (UEI) is JGZFBDAL61C4.

What is Phusis Therapeutics, Inc.'s most recent federal award?

Phusis Therapeutics, Inc.'s most recent federal grant award is Clinical evaluation of a novel AKT/PDK1 inhibitor, PHT-427, for the treatment of multi-field actinitc keratoses (R44CA306740), from National Cancer Institute (NIH), on September 15, 2025.

On GovTribe

See Phusis Therapeutics, Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login

Find teaming partners on GovTribe